Flex Work policy
Corporate Policy
Employee's choice
About
Alnylam Pharmaceuticals, Inc., founded in 2002, is a global biopharmaceutical company that aims to develop novel therapeutics based on RNA interference (RNAi) for genetically defined diseases. The company's mission is to harness a promising new form of drug discovery known as RNAi therapeutics to turn scientific possibility into reality and improve patient health and well-being. Headquartered in Cambridge, Massachusetts, USA, Alnylam has additional office locations in Zug, Switzerland; Maidenhead, UK; Amsterdam, Netherlands; and Tokyo, Japan.
This content was generated by A.I. Alnylam Pharmaceuticals employees can edit to make any changes.